Apixaban

Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will hit the Market
Drug Patent Watch
Wed, 08/12/20 - 10:43 am
generics
FDA
drug approvals
Apixaban
FDA Grants New Indication For Pfizer/Bristol Anticoagulant
Forbes
Sat, 03/15/14 - 10:12 am
Pfizer
DVT
Bristol-Myers Squibb
Apixaban
anticoagulants
Eliquis
Biosimilars Could Be An Unlikely Boost For Pfizer
Seeking Alpha
Wed, 04/3/13 - 10:46 am
biosimilars
Pfizer
trastuzumab
Apixaban
tofacitinib
Studies Examine Novel Use For New Oral Anticoagulant Drugs Comment Now Follow Comments
Forbes
Thu, 02/21/13 - 11:11 am
anticoagulants
dabigatran
Apixaban
Replacing Coumadin: A $10 Billion Opportunity
Seeking Alpha
Mon, 02/13/12 - 07:58 pm
Coumadin
Eliquis
Pfizer
Apixaban
Bristol-Myers Squibb
Xarelto
Bayer
JNJ
Pradaxa
Boehringer Ingelheim
Apixaban- Pfizer's Multi-Billion Dollar Income Replacement For Lipitor
Seeking Alpha
Sat, 12/10/11 - 12:48 pm
Apixaban
Pfizer
anticoagulants
Doctors reserve judgement on new blood clot drugs
Reuters
Tue, 11/15/11 - 12:36 pm
physicians
bloodthinners
Apixaban
Xarelto
Pradaxa
Bayer
Boehringer Ingelheim
JNJ
Pfizer
Bristol-Myers Squibb
Bristol, Pfizer clot drug fails to help ill patients
Reuters
Sun, 11/13/11 - 12:12 pm
Bristol-Myers Squibb
Pfizer
Eliquis
Apixaban
anticoagulants
ELIQUIS® (apixaban) was Superior to Warfarin for the Reduction of Stroke or Systemic Embolism with Significantly Less Major Bleeding in Patients with Atrial Fibrillation in Phase 3 ARISTOTLE Trial
Yahoo/BusinessWire
Sun, 08/28/11 - 12:22 pm
Eliquis
Apixaban
Warfarin
atrial fibrillation
stroke
Bristol-Myers Squibb
Pfizer
ARISTOTLE trial
Pfizer & Bristol-Myers to Release Highly Anticipated Data on Bloodthinner Hopeful
Motley Fool
Wed, 08/24/11 - 10:19 am
Pfizer
Bristol-Myers Squibb
Eliquis
bloodthinners
Apixaban
Data may prove Bristol, Pfizer drug a winner
Yahoo/Reuters
Mon, 08/22/11 - 11:40 am
Pfizer
stroke
Bristol-Myers Squibb
bloodthinners
Eliquis
Apixaban
3 Biotech Drugs With Promising Phase III Data, Moving Into FDA Review
Motley Fool
Fri, 07/1/11 - 09:44 am
FDA
Bristol-Myers Squibb
AstraZeneca
Pfizer
Incyte
Novartis
ruxolitinib
Apixaban
Dapagliflozin
Pfizer, Bristol-Myers Blood Thinner Tops Warfarin in Stroke
Bloomberg
Thu, 06/23/11 - 08:55 am
Warfarin
Pfizer
blood thinners
Bristol-Myers Squibb
Apixaban
Analysis: Data may help Bristol/Pfizer clot drug catch rivals
CNBC
Fri, 06/17/11 - 09:42 am
Pfizer
blood thinners
Bristol-Myers Squibb
Apixaban
Boehringer Ingelheim
Pradaxa
JNJ
Xarelto
Bayer
EMA Recommends Approval for Pfizer, Bristol-Myers’ Eliquis
Bloomberg
Fri, 03/18/11 - 10:22 am
EMA
Europe
Eliquis
Pfizer
blood thinners
Apixaban
Pfizer, Bristol-Myers Blood Thinner Stops Clots Better Than Sanofi Drug
Bloomberg
Wed, 12/22/10 - 09:49 pm
Pfizer
Bristol-Myers Squibb
blood thinners
Apixaban
Lovenox
Sanofi
Pfizer's Mixed Bag
Motley Fool
Tue, 11/23/10 - 08:55 am
Pfizer
Apixaban
JNJ
Boehringer Ingelheim
Bristol-Myers Squibb
Axitinib
Pfizer, Bristol-Myers slip on drug setback
Marketwatch
Fri, 11/19/10 - 11:17 am
Pfizer
Bristol-Myers Squibb
Apixaban
FDA halts Pfizer blood thinner study due to bleeding
Yahoo/AP
Thu, 11/18/10 - 07:02 pm
Pfizer
blood thinners
FDA
Apixaban
Catalyst for Pfizer and Bristol Expected in 2011
Minyanville
Tue, 08/31/10 - 05:38 pm
Pfizer
Bristol-Myers Squibb
Apixaban

Pages